Literature DB >> 1124137

Origin and extrarenal elimination of uric acid in man.

L B Sorensen, D J Levinson.   

Abstract

The origin of uric acid, metabolic pathways of purine metabolism and the disposition of uric acid in normal man are reviewed. Two thirds of the uric acid is normally excreted through the kidney while one third gains entrance to the gut where it undergoes uricolysis. The pathogenesis of hyperuricemia in primary and secondary gout is discussed. Increased production or decreased excretion of uric acid are the two principal mechanisms of hyperuricemia. The known biochemical defects associated with primary overproduction gout are outlined. Extrarenal uricolysis assumes a greater role when the renal excretion of uric acid is compromised.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1124137     DOI: 10.1159/000180432

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  30 in total

1.  Urinary uric acid levels and discoloration of diapers in healthy neonates.

Authors:  Serhan Küpeli; Murat Yurdakök; Gamze Kilinc; Emel Bilgetekin
Journal:  Pediatr Nephrol       Date:  2005-06-08       Impact factor: 3.714

2.  Identification of a Formate-Dependent Uric Acid Degradation Pathway in Escherichia coli.

Authors:  Yumi Iwadate; Jun-Ichi Kato
Journal:  J Bacteriol       Date:  2019-05-08       Impact factor: 3.490

3.  Serum urate concentrations in homozygous sickle cell disease.

Authors:  K De Ceulaer; A G Morgan; E Choo-Kang; W A Wilson; G R Serjeant
Journal:  J Clin Pathol       Date:  1981-09       Impact factor: 3.411

4.  An aminotransferase branch point connects purine catabolism to amino acid recycling.

Authors:  Ileana Ramazzina; Roberto Costa; Laura Cendron; Rodolfo Berni; Alessio Peracchi; Giuseppe Zanotti; Riccardo Percudani
Journal:  Nat Chem Biol       Date:  2010-09-19       Impact factor: 15.040

5.  Uric acid transporter ABCG2 is increased in the intestine of the 5/6 nephrectomy rat model of chronic kidney disease.

Authors:  Hirofumi Yano; Yoshifuru Tamura; Kana Kobayashi; Masayuki Tanemoto; Shunya Uchida
Journal:  Clin Exp Nephrol       Date:  2013-04-13       Impact factor: 2.801

Review 6.  Time to target uric acid to retard CKD progression.

Authors:  Takanori Kumagai; Tatsuru Ota; Yoshifuru Tamura; Wen Xiu Chang; Shigeru Shibata; Shunya Uchida
Journal:  Clin Exp Nephrol       Date:  2016-06-23       Impact factor: 2.801

Review 7.  Hyperuricemia and nonalcoholic fatty liver disease: from bedside to bench and back.

Authors:  Chengfu Xu
Journal:  Hepatol Int       Date:  2015-12-15       Impact factor: 6.047

8.  Serum uric acid and the risk of mortality during 23 years follow-up in the Scottish Heart Health Extended Cohort Study.

Authors:  Stephen P Juraschek; Hugh Tunstall-Pedoe; Mark Woodward
Journal:  Atherosclerosis       Date:  2014-01-30       Impact factor: 5.162

Review 9.  Renal transport of uric acid: evolving concepts and uncertainties.

Authors:  Ion Alexandru Bobulescu; Orson W Moe
Journal:  Adv Chronic Kidney Dis       Date:  2012-11       Impact factor: 3.620

10.  Total saponins from dioscorea septemloba thunb reduce serum uric acid levels in rats with hyperuricemia through OATP1A1 up-regulation.

Authors:  Yan Chen; Xiao-Lin Chen; Ting Xiang; Bao-Guo Sun; Hao-Xuan Luo; Meng-Ting Liu; Ze-Xiong Chen; Shi-Jun Zhang; Chang-Jun Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.